The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs, International Journal of Peptide Research and Therapeutics, vol.12, pp.79-91, 2006. ,
Phage display screening against a set of targets to establish peptide-based sugar mimetics and molecular docking to predict binding site, Bioorganic & medicinal chemistry, vol.17, pp.4825-4832, 2009. ,
A CD44 specific peptide developed by phage display for targeting gastric cancer, Biotechnology letters, vol.37, pp.2311-2320, 2015. ,
Phage display screening identifies a novel peptide to suppress ovarian cancer cells in vitro and in vivo in mouse models, BMC cancer, vol.15, 2015. ,
Screening of a specific peptide binding to esophageal squamous carcinoma cells from phage displayed peptide library, Molecular and cellular probes, vol.29, pp.182-189, 2015. ,
EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies, Trends in microbiology, vol.12, pp.356-360, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-00120139
The significance of LMP1 expression in nasopharyngeal carcinoma, Seminars in cancer biology, vol.12, pp.473-487, 2002. ,
LMP1 TRAFficking activates growth and survival pathways, Advances in experimental medicine and biology, vol.597, pp.173-187, 2007. ,
The Latent Membrane Protein 1 (LMP1), Current topics in microbiology and immunology, vol.391, pp.119-149, 2015. ,
LMP1 structure and signal transduction, Seminars in cancer biology, vol.11, pp.435-444, 2001. ,
Unique signaling properties of CTAR1 in LMP1-mediated transformation, Journal of virology, vol.81, pp.9680-9692, 2007. ,
The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity, PLoS biology, vol.6, 2008. ,
Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis, Cancer gene therapy, vol.12, pp.647-654, 2005. ,
Modulation of LMP1 protein expression by EBV-encoded microRNAs, Proceedings of the National Academy of Sciences of the United States of America, vol.104, pp.16164-16169, 2007. ,
T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivo, Journal of biomedical research, vol.28, pp.468-475, 2014. ,
Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells, Cell cycle, vol.6, pp.1379-1385, 2007. ,
Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma, Therapeutics and clinical risk management, vol.10, pp.721-736, 2014. ,
Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity, Cancer Biology & Therapy, vol.15, pp.61-68, 2014. ,
The biology of EBV infection in human epithelial cells, Seminars in cancer biology, vol.22, pp.137-143, 2012. ,
EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration, Cancer research, vol.68, pp.6997-7005, 2008. ,
Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition, Mol Cancer, vol.9, 2010. ,
Phage display selection and evaluation of cancer drug targets, Current cancer drug targets, vol.3, pp.119-129, 2003. ,
Identification of a novel aFGF-binding peptide with anti-tumor effect on breast cancer from phage display library, Biochemical and biophysical research communications, vol.445, pp.795-801, 2014. ,
Identification of a peptide specifically targeting ovarian cancer by the screening of a phage display peptide library, Oncology letters, vol.11, pp.4022-4026, 2016. ,
The further characterization of the peptide specifically binding to gastric cancer, Molecular and cellular probes, vol.30, pp.125-131, 2016. ,
LMP1 Transmembrane Domain 1 and 2 (TM1-2) FWLY Mediates Intermolecular Interactions with TM3-6 To Activate NF-?B, Journal of virology, vol.80, pp.10787-10793, 2006. ,
The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells, Journal of virology, vol.86, pp.4380-4393, 2012. ,
The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B, The Journal of biological chemistry, vol.267, pp.24157-24160, 1992. ,
Structure of a eukaryotic SWEET transporter in a homotrimeric complex, Nature, vol.527, pp.259-263, 2015. ,
Anabaena Sensory Rhodopsin: A Photochromic Color Sensor at 2.0 Å, Science, vol.306, pp.1390-1393, 2004. ,
Structure of the YajR transporter suggests a transport mechanism based on the conserved motif A, Proceedings of the National Academy of Sciences of the United States of America, vol.110, pp.14664-14669, 2013. ,
Structure of the membrane domain of respiratory complex I, Nature, vol.476, pp.414-420, 2011. ,
, A Hybrid Approach to G Protein-Coupled Receptor Structure Modeling and the Application to the Human Genome. Structure, vol.23, p.7, 1993.
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids, Nucleic Acids Research, vol.35, pp.375-383, 2007. ,
Phage-display screening identifies LMP1-binding peptides targeting the C-terminus region of the EBV oncoprotein, Peptides, vol.85, pp.73-79, 2016. ,
An integrated suite of fast docking algorithms, Proteins, vol.78, pp.3197-3204, 2010. ,
FireDock: fast interaction refinement in molecular docking, Proteins, vol.69, pp.139-159, 2007. ,
Atomic-level protein structure refinement using fragment guided molecular dynamics conformation sampling, Structure, vol.19, pp.1784-1795, 1993. ,